Variant NM_000492.4:c.3745G>A


Variant details:
Name NM_000492.4:c.3745G>A
Protein name NP_000483.3:p.(Gly1249Arg)
Genomic name (hg19)     chr7:g.117282519G>A    UCSC    
Genomic name (hg38) chr7:g.117642465G>A    UCSC
#Exon/intron exon 23
Legacy Name G1249R
Class disease-causing
Subclass CF-causing
WT sequence GGGCCTCTTGGGAAGAACTGGATCA G GGAAGAGTACTTTGTTATCAGCTTT
Mutant sequence GGGCCTCTTGGGAAGAACTGGATCA A GGAAGAGTACTTTGTTATCAGCTTT

Other databases:
dbSNP
rs397508602



Pathogenicity predictors:



Response to modulators:


Modulator FDA approval EMA approval in vitro / ex vivo data clinical data
IVA yesnoyesno
TEZ-IVA yesnoyesno
ELX-TEZ-IVA yes yesyesno
VNZ-TEZ-DIVA yesnoyesno

clinical and functional data presented above are provided by Vertex



Reference PMID Modulator in vitro / ex vivo data clinical data Patient responsiveness
Burgel et al., 2024 39151434 ELX-TEZ-IVAN.D. yes yes



No patient found in CFTR-NGS catalogue


8 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 8
CF 7
CFTR-RD1
  • Other  1




Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing

Detailed genotypes:
Phenotype Patient ID Variant status Additional variants
CF 762heterozygoteCF-causing- Undef
CF 4164heterozygoteCF-causing - Trans
CF 4165heterozygoteCF-causing - Trans
CF 4231heterozygoteCF-causing - Trans
CF 4307heterozygoteCF-causing - Trans
CF 4817heterozygoteCF-causing - Trans
CF 1555homozygotec.3745G>A - p.(Gly1249Arg) - Trans
Other 4262heterozygote


Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing



            CFTR variants are clustered into five groups (click here for more details about the classification of variants):
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.



Go to CFTRare